NCT05654493View on ClinicalTrials.gov

Use of Micropulse Trans-Scleral Cyclophotocoagulation Laser (MP-TSCPC) for Glaucoma Patients

NAActive, not recruitingINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

April 18, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Glaucoma
Interventions
DEVICE

MicroPulse Transscleral Laser Therapy using revised P3 Delivery Device

The MicroPulse G-Probe was applied to the superior and inferior hemispheres of the eye under varied treatment times and sweep numbers

Trial Locations (1)

32224

Mayo Clinic Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05654493 - Use of Micropulse Trans-Scleral Cyclophotocoagulation Laser (MP-TSCPC) for Glaucoma Patients | Biotech Hunter | Biotech Hunter